Metal vs plastic stents for preoperative biliary drainage in patients with periampullary cancer: An updated systematic review and meta‐analysis
Background/Purpose Metal stents (MS) are recommended for preoperative biliary drainage (PBD) in patients with periampullary cancer, but whether MS are superior in terms of re‐intervention and direct cost is debatable. This study aimed to compare the effects of MS and PS on the outcomes of patients w...
Saved in:
| Published in: | Journal of hepato-biliary-pancreatic sciences Vol. 30; no. 1; pp. 6 - 20 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Japan
Wiley Subscription Services, Inc
01.01.2023
|
| Subjects: | |
| ISSN: | 1868-6974, 1868-6982, 1868-6982 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background/Purpose
Metal stents (MS) are recommended for preoperative biliary drainage (PBD) in patients with periampullary cancer, but whether MS are superior in terms of re‐intervention and direct cost is debatable. This study aimed to compare the effects of MS and PS on the outcomes of patients with periampullary cancer.
Methods
For this random‐effects meta‐analysis, electronic databases were screened for randomized controlled trials (RCTs) published until January 2022. Subgroup analyses were performed basis on the center type and presence of NAC.
Results
In this meta‐analysis, seven RCTs (440 participants) were included. MS reduced re‐interventions (risk ratio [RR] = 0.42, 95% confidence interval [CI] = 0.25‐0.72) and direct costs (mean difference = −474 USD, 95% CI = −656 to −292). PBD‐related complications (RR = 0.74, 95% CI = 0.32‐1.71) and postoperative complications (RR = 0.73, 95% CI = 0.45‐1.17) did not differ between MS and PS. Compared PS, MS reduced postoperative complications in high‐volume centers (RR = 0.64, 95% CI = 0.49‐0.84) and PBD‐related complications in patients receiving NAC (RR = 0.29, 95% CI = 0.08‐1.08).
Conclusions
Metal stents likely reduces re‐interventions and direct costs. Further studies are needed to confirm the effects of MS on the outcomes. |
|---|---|
| Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Feature-1 ObjectType-Review-4 content type line 23 ObjectType-Undefined-3 |
| ISSN: | 1868-6974 1868-6982 1868-6982 |
| DOI: | 10.1002/jhbp.1162 |